TRILEPTAL
Live / Registered — Registered and renewed (as of 30 Aug 2018)
What this means for you
Registered since 01 Sept 1998. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 01 Sept 2018).
Record
- Serial number
- 74519619
- Registration number
- 2186101
- Mark type
- Word mark
- Filed
- 02 May 1994
- Published for opposition
- 14 Mar 1995
- Registered
- 01 Sept 1998
- Next maintenance due
- 01 Sept 2018
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: anti-epileptic drug
Owner
- Novartis Corporation, Summit, NJ, US
- Ciba-Geigy Corporation, Ardsley, NY, US
- Ciba-Geigy Corporation, Ardsley, NY, US
- Ciba-Geigy Corporation, Ardsley, NY, US
Prosecution history
- 30 Aug 2018 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 30 Aug 2018 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 30 Aug 2018 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 30 Aug 2018 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 22 Aug 2018 — TEAS SECTION 8 & 9 RECEIVED
- 01 Sept 2017 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 27 Jun 2009 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 27 Jun 2009 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 26 Feb 2008 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 26 Feb 2008 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 19 Feb 2008 — ASSIGNED TO PARALEGAL
- 14 Feb 2008 — TEAS SECTION 8 & 9 RECEIVED
- 08 Aug 2007 — CASE FILE IN TICRS
- 04 Dec 2004 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 18 Nov 2004 — PAPER RECEIVED